COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,234 Articles (22,733 medRxiv, 8,501 bioRxiv)

Most recent first Previous |  Page 1422: Articles 14211-14220  | Next

SARS-CoV-2 Breakthrough Infections in Fully Vaccinated Individuals
Ramirez, E., Wilkes, R. P., Carpi, G., Dorman, J., Bowen, C., Smith, L.
10.1101/2021.06.21.21258990 — Posted: 2021-06-25
Digital contact tracing contributes little to COVID-19 outbreak containment
Burdinski, A., Brockmann, D., Maier, B. F.
10.1101/2021.06.21.21259258 — Posted: 2021-06-25
SARS-CoV-2 Variants are Selecting for Spike Protein Mutations that Increase Protein Stability
Shorthouse, D., Hall, B. A.
10.1101/2021.06.25.449882 — Posted: 2021-06-25 Discussion: Offsite
Engineered chimeric T cell receptor fusion construct (TRuC)-expressing T cells prevent translational shutdown in SARS-CoV-2-infected cells
Godbole, I., Ciminski, K., Yousefi, O. S., Pathan-Chhatbar, S., Saltukoglu, D., Vesper, N., Salavei, P., Strietz, J., Gensch, N., Reth, M., Schwemmle, M., Schamel, W. W.
10.1101/2021.06.25.449871 — Posted: 2021-06-25
A random priming amplification method for whole genome sequencing of SARS-CoV-2 and H1N1 influenza A virus.
Chrzastek, K., Tennakoon, C., Bialy, D., Freimanis, G. L., Flannery, J., Shelton, H.
10.1101/2021.06.25.449750 — Posted: 2021-06-25
Phylogenetic network analysis revealed the recombinant origin of the SARS-CoV-2 VOC202012/01 (B.1.1.7) variant first discovered in U.K.
Xie, X., Lewis, T.-J., Green, N., Wang, Z.
10.1101/2021.06.24.449840 — Posted: 2021-06-25
Risk factors for long COVID: analyses of 10 longitudinal studies and electronic health records in the UK
Thompson, E. J., Williams, D. M., Walker, A. J., Mitchell, R. E., Niedzwiedz, C. L., Yang, T. C., Huggins, C., Kwong, A. S. F., Silverwood, R., Di Gessa, G., Bowyer, R. C. E., Northstone, K., Hou, B., Green, M. J., Dodgeon, B., Doores, K. J., Duncan, E., Williams, F. M. K., OpenSAFELY Collaborative, , Steptoe, A., Porteous, D. J., McEachan, R. R. C., Tomlinson, L., Goldacre, B., Patalay, P., Ploubidis, G. B., Katikireddi, S. V., Tilling, K., Rentsch, C. T., Timpson, N. J., Chaturvedi, N., Steves, C. J.
10.1101/2021.06.24.21259277 — Posted: 2021-06-25
Meta-Analytic Evidence of Depression and Anxiety in Eastern Europe during the COVID-19 Pandemic
Zhang, S. X. O., Miller, S. O., Xu, W., Yin, A., Chen, B., Delios, A., Dong, R. K., Chen, R. Z., McIntyre, R., Wan, X., Wang, S., Chen, J.
10.1101/2021.06.21.21259227 — Posted: 2021-06-25
COVID-19 Susceptibility, Mortality, and Length of hospitalization based on age-sex composition: Evidence from Davao Region Philippines
Ceballos, R.
10.1101/2021.06.20.21259222 — Posted: 2021-06-25
Socioeconomic position and SARS-CoV-2 infections: seroepidemiological findings from a German nationwide dynamic cohort
Hoebel, J., Grabka, M. M., Schroeder, C., Haller, S., Neuhauser, H., Wachtler, B., Schaade, L., Liebig, S., Hoevener, C., Zinn, S.
10.1101/2021.06.21.21259001 — Posted: 2021-06-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).